A Winn Foundation
Report On ...
Hypertrophic Cardiomyopathy in Maine Coon Cats
Report on Hypertrophic
Cardiomyopathy in Maine Coon Cats from the First International Feline Genetic
Disease Conference held June 25-28, 1998 at the University of Pennsylvania,
Philadelphia, PA (Updated with Grant Progress Report)
by Susan Little,
DVM, Diplomate ABVP (Feline)
The two primary
researchers into heritable hypertrophic cardiomyopathy (HCM) in Maine
Coon cats are Dr. Mark Kittleson of the University of California at Davis
and Dr. Kathryn Meurs of The Ohio State University. Both researchers were
present at the Feline Genetic Disease Conference for presentations on
HCM and question and answer sessions with both veterinarians and breeders.
Dr. Kittleson's
presentation began with an overview of HCM in humans, where it is known
to be inherited in an autosomal dominant fashion and
has an adult onset. While there are currently over 100 mutations identified
in seven different genes that can be responsible for HCM in people, the
clinical signs and progress of the disease are often the same. The most
common genetic defect involves a mutation in a gene that codes for the
structure of an integral muscle protein (the beta-myosin heavy chain)
in the individual heart muscle cell. Myosin is a protein that makes up
about 65% of all the protein in a muscle cell. It consists of long chains
of polypeptide components that are joined to each other by side chains.
Myosin is one of the proteins responsible for contraction of heart muscle.
In cats, HCM is
the most common cardiac disease. Most cats are middle-aged at the onset
of their clinical symptoms, but patients as young as one year old and
as old as 13 years have been identified. The average cat with severe HCM
and heart failure lives for only several months despite therapy.
The first investigations
into HCM in Maine Coons started when Marcia Munro, a private cat owner
from Connecticut, contacted Dr. Kittleson about her affected Maine Coon
cat and the related cats she had identified with HCM. All the cats from
the cattery of origin were ultrasounded, and one unaffected male was bred
to three affected females to start a research colony. In the research
colony, ultrasounds were done starting at three to six months of age and
were done every four to eight months afterward. Breeding records showed
that HCM was inherited as an autosomal dominant trait in this colony.
Breeding an affected cat to any other cat always produced at least one
affected kitten in the litter. Equal numbers of males and females are
affected. In Dr. Kittleson's colony, no cats with HCM were identified
before one year of age when test breedings were done between affected
cats and non-affected cats. The
disease was often evident
by two years of age and could be very severe by two to four years of age.
Males seemed to have more severe disease and were affected earlier. When
affected cats were bred to other affected cats, however, HCM appeared
as early as three months of age; severe disease could occur by six to
18 months of age and males and females were affected in the same way.
In the general cat population, cats with severe HCM will usually die of
their disease. More males die of HCM and there may be no symptoms until
the sudden death of the cat.
Dr. Kittleson
identified certain characteristics of the HCM in Maine Coon cats that
can be seen on ultrasound. Two changes in particular, called systolic
interior motion of the mitral valve and papillary muscle hypertrophy,
are commonly seen in Maine Coons with HCM. Dr. Meurs investigated the
possibility that the genetic defect in HCM in cats is similar to that
in people (i.e., it is in the beta-myosin heavy chain). Her studies found,
however, that while cats often had genetic differences in the beta-myosin
heavy chain, they were not differences that affected the production of
the protein. Attention has now turned to other genes that make proteins
that are part of the contractile element (the assembled proteins responsible
for contraction) in heart muscle to determine if one of them is responsible
for familial feline HCM. These include the myosin light chains and myosin
binding protein C genes. In humans there is a rare form of HCM that involves
a defect in the myosin light chains that produces primarily papillary
muscle hypertrophy.
Dr. Kittleson
has also looked at HCM in other breeds, including the American Shorthair.
The disease in this breed is also inherited as an autosomal dominant trait;
however, the disease commonly is not as severe.
Dr. Kittleson's
recommendations for screening Maine Coon cats for breeding depend on the
sex of the cat. He recommends that male cats be screened at two years
of age or older (because they often have earlier and more severe disease)
and female cats be screened later, perhaps at three to four years of age.
He stressed that it is very important to have an ultrasonographer who
is familiar with the particular components of HCM in Maine Coons as the
early changes (such as left papillary muscle hypertrophy) might be missed
by the uninformed person.
Resources
Dr. Kittleson's
work has been presented at recent veterinary conferences in addition to
the Feline Genetic Disease Conference:
- Meurs K, Kittleson
MD, Towbin J, Ware W. Familial systolic anterior motion of the mitral
valve and/or hypertrophic cardiomyopathy is apparently inherited as
an autosomal dominant in a family of American Shorthair cats. Proceedings
of the 15th American College of Veterinary Internal Medicine Forum,
Lake Buena Vista, FL, 1997.
- Kittleson MD,
Meurs KM, Kittleson J, Munro M, Liu S, Towbin JA. Heritable characteristics,
phenotypic expression, and natural history of hypertrophic cardiomyopathy
in Maine Coon cats. Proceedings of the 16th American College of Veterinary
Internal Medicine Forum, San Diego, CA, 1998.
The research has
also been published in the following journals/books:
- Kittleson MD.
Development and progression of inherited hypertrophic cardiomyopathy
in Maine Coon cats (abstract). J Vet Internal Med, Vol 10, No 3, p 165,
1996.
- Meurs K, Kittleson
MD, Towbin J, Ware W. Familial systolic anterior motion of the mitral
valve and/or hypertrophic cardiomyopathy is apparently inherited as
an autosomal dominant in a family of American Shorthair cats. J Vet
Internal Med, Vol 11, No 2, p 138, 1997.
- Kittleson MD,
Kienle RD. Small Animal Cardiovascular Medicine, Mosby, St. Louis, MO,
1998.
All chromosomes are
present in pairs, except for the sex chromosome (X and Y). The chromosomes
other than X and Y are called autosomes. A genetic trait that is inherited
on the non-sex chromosomes is called autosomal. A genetic trait that is
inherited on the sex chromosomes is termed "sex-linked." Most traits are
autosomal, including HCM in cats.
The chromosomes contain
thousands of genes. Since each autosome is paired, genes on those chromosomes
are present in pairs. Each time a body cell divides, the genes multiply
with a process of self-copying which is highly accurate. Occasionally,
an inexact copy of a gene is made and this is termed a "mutant." Variations
from normal types or conditions usually occur as the result of mutations,
and this is the case for HCM. When a disease is caused by a mutation in
a gene that codes for a structural or functional protein, a mutation in
only one copy of the gene ("allele") can produce disease since a full
complement of the protein is needed for the affected organ to function
normally. When only one allele (either from the mother or father) needs
to be affected to cause disease, it is an autosomal dominant trait. Mutations
in genes that code for enzymes usually need both alleles (one each from
the mother and father) affected since enzyme systems generally have to
be suppressed to less than 10% of their normal level to produce an effect
(in this case a disease). This is called an autosomal recessive disease.
Only one copy of the mutant gene (one allele) is needed to produce HCM
in a cat.
The Winn Feline Foundation,
Inc.
1805 Atlantic Avenue
P.O. Box 1005
Manasquan, New Jersey
08736-0805
Tel: (732) 528-9797
Copyright © 1997-2000
The Winn Feline Foundation, Inc. Please send comments to winn@winnfelinehealth.org.
|